EWA
JAZZ icon

EverSource Wealth Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

EverSource Wealth Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Sell
1,122
-398
-26% -$87.2K 0.01% 856
2026
Q1 		$287K Buy
1,520
+739
+95% +$129K 0.01% 864
2025
Q4 		$133K Sell
781
-202
-21% -$31K ﹤0.01% 1165
2025
Q3 		$130K Buy
983
+81
+9% +$9.71K 0.01% 1136
2025
Q2 		$95.7K Buy
902
+313
+53% +$34K ﹤0.01% 1231
2025
Q1 		$73.1K Sell
589
-31
-5% -$4.04K ﹤0.01% 1048
2024
Q4 		$76.4K Buy
620
+305
+97% +$35.9K ﹤0.01% 1008
2024
Q3 		$35.1K Buy
315
+42
+15% +$4.6K ﹤0.01% 1222
2024
Q2 		$30.1K Buy
273
+97
+55% +$10.7K ﹤0.01% 1319
2024
Q1 		$19.5K Buy
176
+67
+61% +$8.21K ﹤0.01% 1375
2023
Q4 		$13.4K Buy
109
+18
+20% +$2.25K ﹤0.01% 1427
2023
Q3 		$11.8K Buy
91
+28
+44% +$3.73K ﹤0.01% 1357
2023
Q2 		$7.81K Sell
63
-3
-5% -$404 ﹤0.01% 1556
2023
Q1 		$9.66K Buy
66
+6
+10% +$888 ﹤0.01% 1376
2022
Q4 		$9.56K Buy
60
+24
+67% +$3.52K ﹤0.01% 1350
2022
Q3 		$5K Hold
36
– – ﹤0.01% 1371
2022
Q2 		$6K Sell
36
-7
-16% -$1.08K ﹤0.01% 1200
2022
Q1 		$7K Sell
43
-5
-10% -$726 ﹤0.01% 1137
2021
Q4 		$6K Buy
+48
New +$6.31K ﹤0.01% 1184

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

EverSource Wealth Advisors's JAZZ Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Jazz Pharmaceuticals (JAZZ) stake by 26% in Q2 2026, selling an estimated $87.2K and leaving 1,122 shares worth $270K. The position accounts for 0.01% of the portfolio, ranked #856.

EverSource Wealth Advisors first reported a position in JAZZ in Q4 2021 and has held it in 19 quarters since. The position peaked at $287K in Q1 2026. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • EverSource Wealth Advisors held 1,122 shares of Jazz Pharmaceuticals worth $270K as of Q2 2026.
  • EverSource Wealth Advisors sold 398 Jazz Pharmaceuticals shares in Q2 2026, an estimated $87.2K.
  • Jazz Pharmaceuticals made up 0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #856 holding.
  • EverSource Wealth Advisors first reported a position in Jazz Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • EverSource Wealth Advisors's Jazz Pharmaceuticals position peaked at $287K in Q1 2026.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.